SANASana Biotechnology, Inc.
$2.80-32% 1Y
$2.80
$2.6852 weeks$5.92
Price
-32%1YEnd-of-day closes, not the intraday tick.
RyuScore
Weak, higher than 6% of companiesThe five questions
2 of 5 availableOnly two of the five can be answered for SANA today. The rest need figures this filer has not published. The tabs above still show whatever data does exist.
- Is the business good?not enough filed
- Is it safe?Watch
- Is the price fair?not enough filed
- Is it growing?not enough filed
- What is the market doing?Watch
P/En/a
Market value$777.8M
1 year-32%
5 years-88%
Charts
As reported to the SEC, without any scoring.
The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 8, 2026Corporate Presentation September 2026.Regulation FD disclosure · press release
- Aug 10, 2026Sana Biotechnology Reports Second Quarter 2026 Financial Results and Business Updates.Earnings release · press release
- May 15, 2026Sana Biotechnology, Inc. Date: May 15, 2026 By: /s/ Aaron M. Grossman Aaron M. Grossman Executive Vice President, Chief Legal Officer.Other event · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.